comparable

Verseon Acquires Edammo to Deepen Drug Discovery Approach

Published: Nov 12th, 2022 | By Mark Terry Verseon Corporation has acquired Edammo, an artificial intelligence-focused company, to deepen its own AI-based drug discovery platform, the companies revealed Tuesday. Adityo Prakash, co-founder and CEO of Verseon and Ed Ratner, CEO at Edammo, discussed the acquisition with BioSpace. “We develop completely new drugs on the computer, atom by atom, then we make them in the laboratory,” Prakash said. "We’re changing how small molecule drugs are designed and developed with a level of efficiency that hasn’t been possible before.” He added that

The data platform of the future

The evolution of data science The advent of the Internet in the late 60s and early 70s of the 20th century brought great convenience to mankind. From this initial foundation, mankind has gradually created other related products and applications such as cloud database or blockchain. Cloud database is a technology to store information on a cloud computing platform, so that users can store, manage and access it via the Internet. Blockchain, also known as blockchain technology, is an invention around 2008, contributing an important part to the formation of the